文献速递脑血管病外科神经重症

破裂大型或巨大颅内动脉瘤短期不良功能结局的危险因素与长期耐久性

Risk factors of short-term poor functional outcomes and long-term durability of ruptured large or giant intracranial aneurysms.
PubMed 文献 · J Neurosurg · 2025-01-10

基于日本8家机构的多中心观察数据库,纳入416例破裂大型或巨大(≥10 mm)囊状颅内动脉瘤所致蛛网膜下腔出血患者,出院时不良功能结局(改良Rankin量表评分≥3分)251例(60.3%)。动脉瘤体积增大与不良功能结局显著相关(OR 1.13,95%CI 1.04-1.22;p=0.003),血管内治疗更可能获得更好短期结局(OR 1.56,95%CI 1.41-1.71;p=0.03),但治疗1年后迟发性再出血在血管内治疗组(4.8%)高于直接手术组(0.0%)(p=0.008,log-rank检验)。

要点

  • 出院时不良功能结局(mRS评分≥3分)见于251例(60.3%)破裂大型或巨大颅内动脉瘤患者。
  • 动脉瘤体积增大与不良功能结局显著相关(OR 1.13,95%CI 1.04-1.22;p=0.003)。
  • 血管内治疗与更好短期功能结局相关(OR 1.56,95%CI 1.41-1.71;p=0.03),但1年后迟发性再出血更多(4.8% vs 0.0%;p=0.008)。

核心结论

  • 动脉瘤体积增大被确定为大型或巨大动脉瘤所致蛛网膜下腔出血后不良功能结局的危险因素,并受与其他传统危险因素交互作用的影响。
  • 血管内治疗更可能与更好的短期结局相关,但治疗1年后较高的迟发性再出血率值得关注。

研究设计与样本

  • 研究数据来自日本参与动脉瘤性蛛网膜下腔出血多中心注册数据库的8家机构。
  • 在5095例连续注册的蛛网膜下腔出血患者中,纳入416例由破裂大型或巨大(≥10 mm)囊状颅内动脉瘤所致蛛网膜下腔出血的患者。
  • 采用多变量分析探究不良功能结局的危险因素,随后分析这些危险因素间的交互作用。
  • 最后采用基于倾向评分的方法分析治疗方式(直接手术或血管内治疗)与功能结局的关联。
  • 通过分析再出血评估治疗动脉瘤的长期耐久性。

主要发现

  • 出院时不良功能结局(改良Rankin量表评分≥3分)见于251例(60.3%)患者。
  • 多变量 logistic 回归分析显示,动脉瘤体积增大与不良功能结局显著相关(OR 1.13,95%CI 1.04-1.22;p=0.003)。
  • 交互作用分析显示,动脉瘤体积增大的负面效应在年轻患者、初始神经功能分级良好者及接受直接手术者中更为突出。
  • 基于倾向评分的分析显示,接受血管内治疗的患者有更高机会获得更好功能结局(OR 1.56,95%CI 1.41-1.71;p=0.03)。
  • 生存分析显示,治疗1年后再出血在血管内治疗组(4.8%)比直接手术组(0.0%)更频繁(p=0.008,log-rank检验)。

关键数值与推荐

  • 不良功能结局定义为出院时改良Rankin量表评分≥3分。
  • 大型或巨大动脉瘤定义为直径≥10 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aneurysmal subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality rates. In particular, functional outcomes of SAH caused by large or giant (≥ 10 mm) ruptured intracranial aneurysms are worsened by high procedure-related complication rates. However, studies describing the risk factors for poor functional outcomes specific to ruptured large/giant aneurysms are sparse. In addition, high recurrence and rebleeding rates following treatment of such aneurysms remain a concern. This study aimed to clarify the specific risk factors for poor short-term outcomes and long-term durability of SAH due to ruptured large/giant intracranial aneurysms using a multicenter observational database in Japan. METHODS: Data were obtained from 8 institutions participating in a multicenter repository of aneurysmal SAH in Japan. Among 5095 consecutive registered patients with SAH patients, 416 patients with SAH caused by ruptured large/giant (≥ 10 mm) saccular intracranial aneurysms were included. The authors investigated the risk factors for poor functional outcomes in patients with such aneurysms using multivariable analyses and subsequently investigated the interaction between these risk factors. The association between the treatment modality (direct surgery or endovascular therapy) and functional outcomes were finally analyzed using a propensity score-based method. The long-term durability of the treated aneurysms was evaluated by analyzing rebleeding. RESULTS: Poor functional outcomes (modified Rankin Scale score ≥ 3) at discharge were observed in 251 (60.3%) patients. Increasing aneurysm size was significantly associated with poor functional outcomes (OR 1.13, 95% CI 1.04-1.22; p = 0.003) by a multivariable logistic regression analysis, and such negative effects were more prominent in younger patients, those with a good initial neurological grade, and those treated with direct surgery by interaction analyses. Propensity score-based analysis revealed that patients treated with endovascular therapy had a higher chance of better functional outcomes (OR 1.56, 95% CI 1.41-1.71; p = 0.03). Rebleeding 1 year after treatment was more frequent in the endovascular therapy (4.8%) than in the direct surgery (0.0%) group by survival analysis (p = 0.008, log-rank test). CONCLUSIONS: Increasing aneurysm size was identified as a risk factor for poor functional outcomes after SAH due to large/giant aneurysms and was affected by the interaction with other conventional risk factors. Endovascular therapy was more likely to be associated with better short-term outcomes; however, a higher delayed rebleeding rate after 1 year was a concern.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Fukuda H, Hyohdoh Y, Kawada K, et al. Risk factors of short-term poor functional outcomes and long-term durability of ruptured large or giant intracranial aneurysms. J Neurosurg. 2025. PMID: 39793005. doi:10.3171/2024.8.JNS24894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。